sharecast

{{ storiesRelated.title }}

News And Announcements
17 Sep
national rail ticket
Trainline reports gradual recovery after lockdown collapse in demand

Trainline said on Thursday that the impact of Covid-19 resulted in its net ticket sales decreasing to £358m in the first half, equivalent to 19% of the same period in the prior year.

17 Sep
vesuvius
Vesuvius pays back Covid-19 debt to BoE

Vesuvius said on Thursday that it has elected to repay £200m of debt issued through the Bank of England’s Covid Corporate Financing Facility earlier than its March 2021 maturity thanks to positive free cash flow generation in recent months and early signs of "marginally improving" levels of business activity.

17 Sep
Sun bingo Playtech gambling gaming
Playtech reports strong trading after profit drops

Playtech reported strong but weakening summer trading as the gambling software company posted a sharp fall in first-half profit caused by the Covid-19 crisis.

17 Sep
dividendoscb5
LXI REIT raises quarterly dividend guidance

Real estate investment trust LXI upped its quarterly dividend guidance on Thursday after experiencing some "robust rent collection" in the three months ending 30 September.

17 Sep
london tfl grainger
Grainger gets green light for Southall development from Ealing Council

Residential property group Grainger has been given the green light by Ealing Council for a new development by Southall station.

17 Sep
Hilton Foods lifts dividend as home dining boosts profits

International food packing business Hilton Food lifted its dividend after a sharp rise in interim profits driven by higher volumes.

17 Sep
ep motor de rolls-royce
Rolls-Royce still reviewing funding options

Rolls-Royce is still reviewing a range of funding options to strengthen its balance sheet including debt and equity, but no final decisions have been made, the engine maker said.

17 Sep
Simon Wolfson
Next upgrades profit guidance as sales beat expectations

Next upgraded its profit guidance after sales in the first half and beyond held up better than the company expected.

17 Sep
Oxford Biomedica sees swing to FY profit on Covid vaccine hopes

Drugs maker Oxford Biomedica, which has partnered with pharma giant AstraZeneca to develop a Covid-19 vaccine, said it expected higher second half revenues to push it to a low-to-single digit full year profit.